Implantable Cardioverter-Defibrillator Use in the VA System

Phase 3

Completed

• Conditions: Cardiomyopathies
• Interventions: Behavioral: Clinical Reminder

• Registration Number: NCT01217827
• Lead Sponsor: Stanford University

Brief Summary

Despite being a proven life-saving intervention in appropriately selected individuals, multiple studies continue to demonstrate low implantation of defibrillators in potential candidates. Based upon prior research, a major barrier to low utilization is low referral of potential candidates by healthcare providers. In this study, via brief clinical reminder placed in the electronic medical record, we ask healthcare providers who have not referred potential candidates for defibrillator the reasons for this decision and provide them with the tools for referral if appropriate.

Detailed Description

Not available

Study Timeline

• Study Start: 2010-04
• Study First Submitted: 2010-10-07
• Study First Submitted QC: 2010-10-07
• Study First Posted: 2010-10-08
• Primary Completion: 2011-01
• Study Completion: 2013-12
• Results First Submitted: 2016-10-13
• Results First Submitted QC: 2016-10-13
• Results First Posted: 2016-12-07
• Status Verified: 2021-04
• Last Update Submitted: 2021-04-30
• Last Update Posted: 2021-05-19

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 89

Inclusion Criteria

Meeting published criteria for receipt of an implantable cardioverter defibrillator

Read More

Exclusion Criteria

provider is not affiliated with the VA health care system

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Clinical Reminder	Clinical Reminder	Reminder of potential candidacy for an implantable cardioverter defibrillator. The reminder is placed in the medical record with copy to the primary provider and any cardiologist managing the patient.

Primary Outcome Measures

Name	Time	Method
Referral for Implantable Cardioverter Defibrillator	6 months	Referral of the patient to electrophysiology clinic for evaluation for cardioverter defibrillator implantation.

Trial Locations

Locations (2)

VA Palo Alto Health Care System; 🇺🇸 Palo Alto, California, United States

Stanford University School of Medicine; 🇺🇸 Stanford, California, United States